BioCardia, Inc. (BCDA)
NASDAQ: BCDA · Real-Time Price · USD
1.200
+0.110 (10.09%)
At close: Jun 26, 2026, 4:00 PM EDT
1.150
-0.050 (-4.17%)
After-hours: Jun 26, 2026, 7:57 PM EDT
BioCardia Employees
As of December 31, 2025, BioCardia had 21 total employees, including 17 full-time and 4 part-time employees. The number of employees increased by 1 or 5.00% compared to the previous year.
Employees
21
Change (1Y)
1
Growth (1Y)
5.00%
Revenue / Employee
n/a
Profits / Employee
-$370,238
Market Cap
13.65M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Lunai Bioworks | 29 |
| BioLineRx | 24 |
| Curis | 24 |
| Citius Pharmaceuticals | 23 |
| IN8bio | 18 |
| CalciMedica | 16 |
| BioVie | 13 |
| Tvardi Therapeutics | 12 |
BCDA News
- 8 days ago - BioCardia issues letter to shareholders on 2026 priorities - TheFly
- 8 days ago - BioCardia Letter to Stockholders on 2026 Priorities and Strategic Opportunities - GlobeNewsWire
- 18 days ago - BioCardia Announces $4.4 Million Financing - GlobeNewsWire
- 21 days ago - FDA confirms CardiAMP Heart Failure II Trial may support premarket approval - TheFly
- 21 days ago - FDA Confirms CardiAMP HF II May Support Premarket Approval of CardiAMP Cell Therapy for Ischemic HFrEF - GlobeNewsWire
- 5 weeks ago - BioCardia Announces CardiAMP Chronic Myocardial Ischemia Trial Results Presented at EuroPCR Showed Durable Improvements in Exercise Tolerance with Reduced Angina Frequency - GlobeNewsWire
- 5 weeks ago - BioCardia Transcript: A.G.P.'s Annual Virtual Healthcare Conference - Transcripts
- 6 weeks ago - BioCardia Earnings Call Transcript: Q1 2026 - Transcripts